Arialys

Arialys Therapeutics

Arialys was founded in 2022, is headquartered in La Jolla, United States, lists 1–10 employees, and has $72.8M in recorded funding across 2 rounds.

Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$72.8M
Last Round
$14.8M Venture RoundJun 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

Arialys Therapeutics is a clinical-stage biotechnology company based in La Jolla, California, developing precision medicines that target autoimmune neuropsychiatric diseases, including anti-NMDA receptor encephalitis. The company was founded by Avalon Bioventures, Catalys Pacific, and MPM to explore recent discoveries in autoimmune neuropsychiatry, with a focus on blocking disease-causing pathogenic antibodies. Its lead candidate, ART5803, holds FDA Rare Pediatric Disease designation.

Summary

Arialys is a Biotech company based in La Jolla, United States, founded in 2022. It lists 1–10 employees. It has raised $72.8M in total across 2 rounds, most recently a $14.8M Venture Round in Jun 2025. Investors include Avalon BioVentures, Alexandria Venture Investments and Catalys Pacific.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundJun 2025
$14.8M

Sign up to see all 2 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Arialys on Indexed.vc
<a href="https://indexed.vc/companies/arialys"><img src="https://indexed.vc/api/badge/company/arialys" alt="Arialys on Indexed.vc" width="260" height="76" /></a>